MARKET

CMRX

CMRX

Chimerix
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.670
+0.030
+1.83%
Closed 16:00 11/11 EST
OPEN
1.640
PREV CLOSE
1.640
HIGH
1.685
LOW
1.610
VOLUME
523.31K
TURNOVER
--
52 WEEK HIGH
4.400
52 WEEK LOW
1.250
MARKET CAP
102.51M
P/E (TTM)
-0.7426
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CMRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CMRX News

  • Edited Transcript of CMRX earnings conference call or presentation 5-Nov-19 1:30pm GMT
  • Thomson Reuters StreetEvents.1h ago
  • Chimerix Inc Officer Andriole Buys 100,000 @$1.56
  • Benzinga.4d ago
  • Should You Be Concerned About Chimerix, Inc.'s (NASDAQ:CMRX) Historical Volatility?
  • Simply Wall St..4d ago
  • Chimerix EPS of -$1.26
  • seekingalpha.6d ago

More

Industry

Biotechnology & Medical Research
-0.51%
Pharmaceuticals & Medical Research
-0.43%

Hot Stocks

Name
Price
%Change

About CMRX

Chimerix, Inc. is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, is in development as an oral and intravenous (IV) formulation for the prevention and treatment of deoxyribonucleic acid (DNA) viruses, including smallpox, adenoviruses (AdV), and the human herpesviruses. It is also advancing the development of CMX521 for the treatment and prevention of norovirus. In addition, the Company has an active discovery program focusing on viral targets for which limited or no therapies are available. Brincidofovir is an investigational oral nucleotide analog that has shown spectrum antiviral activity against all five families of double-stranded deoxyribonucleic acid (dsDNA) viruses that affect humans. Oral and IV formulations of brincidofovir are in development, both of which deliver the active antiviral directly to the site of viral replication.
More

Webull offers Chimerix Inc (CMRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.